Dr. Mark Levis, MD

Claim this profile

Johns Hopkins Cancer Center

Studies Acute Myelogenous Leukemia
Studies Acute Myeloid Leukemia
3 reported clinical trials
6 drugs studied

Area of expertise

1

Acute Myelogenous Leukemia

Mark Levis, MD has run 2 trials for Acute Myelogenous Leukemia. Some of their research focus areas include:

FLT3 positive
NPM1 positive
KMT2A (MLL)-fusion positive
2

Acute Myeloid Leukemia

Mark Levis, MD has run 2 trials for Acute Myeloid Leukemia. Some of their research focus areas include:

FLT3 positive
NPM1 positive
KMT2A (MLL)-fusion positive

Affiliated Hospitals

Image of trial facility.

Johns Hopkins Cancer Center

Image of trial facility.

Johns Hopkins

Clinical Trials Mark Levis, MD is currently running

More about Mark Levis, MD

Clinical Trial Related

3 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 1 Active Clinical Trial

Treatments Mark Levis, MD has experience with

  • Ivosidenib
  • DSP-5336
  • Cytarabine
  • Daunorubicin
  • Gilteritinib
  • Midostaurin

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Mark Levis, MD specialize in?

Is Mark Levis, MD currently recruiting for clinical trials?

Are there any treatments that Mark Levis, MD has studied deeply?

What is the best way to schedule an appointment with Mark Levis, MD?

What is the office address of Mark Levis, MD?

Is there any support for travel costs?

Unbiased Results

We believe in providing patients with all the options.

Your Data Stays Your Data

We only share your information with the clinical trials you're trying to access.

Verified Trials Only

All of our trials are run by licensed doctors, researchers, and healthcare companies.

Terms of Service·Privacy Policy·Cookies·Security